BREEA BUCKLEY: Open Payments
NPI 1447706684 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,755 in 73 payments from 28 companies in 2025. Trend: 2023 $2,450 · 2024 $1,439 · 2025 $1,755
Food & beverage: $1,755
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $234 |
| Merck Sharp & Dohme LLC | 7 | $172 |
| GlaxoSmithKline, LLC. | 6 | $151 |
| Incyte Corporation | 5 | $131 |
| Ipsen Biopharmaceuticals, Inc | 1 | $100 |
| Daiichi Sankyo Inc. | 4 | $100 |
| Gilead Sciences, Inc. | 4 | $95 |
| AstraZeneca Pharmaceuticals LP | 4 | $92 |
| Janssen Biotech, Inc. | 3 | $82 |
| PFIZER INC. | 3 | $73 |
Products named: KEYTRUDA, Enhertu, Onivyde, Trodelvy, OJJAARA, LUTATHERA, JAKAFI, ERLEADA.
Industry payments across FL — which companies pay providers there.
